Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) – Analysts at Leerink Partnrs issued their FY2027 earnings per share estimates for shares of Zentalis Pharmaceuticals in a report released on Tuesday, February 27th. Leerink Partnrs analyst A. Berens anticipates that the company will earn ($2.59) per share for the year. Leerink Partnrs currently has a “Market […]
Leerink Partnrs Weighs in on Zentalis Pharmaceuticals, Inc.'s Q3 2023 Earnings (NASDAQ:ZNTL) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
GSK (NYSE:GSK – Get Free Report) and Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Volatility and Risk GSK has a beta of 0.67, […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) – Investment analysts at HC Wainwright decreased their Q2 2023 earnings per share estimates for shares of Zentalis Pharmaceuticals in a research note issued to investors on Thursday, May 11th. HC Wainwright analyst A. Fein now expects that the company will earn ($1.15) per share for the quarter, […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.